Debra Lucas‐McGady
Papers
1
Total Citations
26
H-Index
1
About
Debra Lucas‐McGady is a prominent researcher in the fields of glycobiology and cancer metastasis, with a particular focus on the enzyme heparanase. Her major contributions center on the development of high-throughput methodologies for measuring heparanase activity, a key driver of tumor invasion and inflammation. Her seminal 2004 work, "High-throughput methods for measuring heparanase activity and screening potential antimetastatic and anti-inflammatory agents," has garnered 26 citations, establishing a foundational platform for drug discovery. This innovation enabled the rapid screening of compounds that inhibit heparanase, paving the way for potential antimetastatic and anti-inflammatory therapies. Lucas‐McGady's work is notable for bridging basic enzymology with translational applications, offering tools that accelerate the identification of therapeutic candidates. Her research has significant implications for understanding how cancer cells degrade the extracellular matrix to spread, and for developing targeted interventions. Through her methodological advances, she has empowered the scientific community to explore heparanase as a druggable target, making her a key figure in the fight against metastatic disease and chronic inflammation.
Research Focus
Key Achievements
Top Papers
- 1